sesamol has been researched along with Hyperlipidemias in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, L; Guo, M; He, Y; Jiang, H; Liu, J; Ren, C; Shi, Y; Sun, M; Wang, B; Wang, W; Wang, X; Xie, Y; Xu, X | 1 |
| Kumar, N; Kutty, NG; Mudgal, J; Nayak, PG; Parihar, VK; Rao, CM | 1 |
| Majdalawieh, AF; Ro, HS | 1 |
| Desikan, R; Kampfrath, T; Kherada, N; Mihai, G; Parthasarathy, S; Rajagopalan, S; Selvendiran, K; Simonetti, O; Sun, Q; Ying, Z; Ziouzenkova, O | 1 |
4 other study(ies) available for sesamol and Hyperlipidemias
| Article | Year |
|---|---|
The combination of sesamol and clofibric acid moieties leads to a novel potent hypolipidemic agent with antioxidant, anti-inflammatory and hepatoprotective activity.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Benzodioxoles; Clofibric Acid; Dose-Response Relationship, Drug; Hyperlipidemias; Hypolipidemic Agents; Inflammation; Liver; Mice; Mice, Inbred Strains; Molecular Docking Simulation; Molecular Structure; Oxidative Stress; Phenols; Polyethylene Glycols; Protective Agents; Structure-Activity Relationship | 2021 |
Sesamol treatment reduces plasma cholesterol and triacylglycerol levels in mouse models of acute and chronic hyperlipidemia.
Topics: Acute Disease; Animals; Antioxidants; Benzodioxoles; Body Weight; Cholesterol; Chronic Disease; Hyperlipidemias; Hypolipidemic Agents; Male; Mice; Phenols; Sesamum; Triglycerides | 2013 |
Sesamol and sesame (Sesamum indicum) oil enhance macrophage cholesterol efflux via up-regulation of PPARγ1 and LXRα transcriptional activity in a MAPK-dependent manner.
Topics: Animals; Benzodioxoles; CHO Cells; Cholesterol; Cricetulus; Hyperlipidemias; Liver X Receptors; Macrophages; Mice; Mice, Inbred C57BL; Orphan Nuclear Receptors; Phenols; PPAR gamma; Rabbits; Sesame Oil; Sesamum; Transcriptional Activation; Up-Regulation | 2015 |
A modified sesamol derivative inhibits progression of atherosclerosis.
Topics: Animals; Aorta; Aortic Diseases; Atherosclerosis; Benzodioxoles; Cardiovascular Agents; Cattle; Cell Adhesion Molecules; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Gene Expression Regulation; Hyperlipidemias; I-kappa B Kinase; I-kappa B Proteins; Magnetic Resonance Imaging; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidative Stress; Phenols; Phosphorylation; Rabbits; Time Factors; Transfection; Vasoconstriction; Vasodilation | 2011 |